STRATEGY STUDIO / NONPROFIT PEOPLE SEARCH

BIOTECHNOLOGY INNOVATION ORGANIZATION: Form 990, tax year 2021

View the entire original 990 at ProPublica ↗

Organization
BIOTECHNOLOGY INNOVATION ORGANIZATION (EIN 52-1224577)
Tax period
2021-01-01 to 2021-12-31
Filed
2022-11-15
IRS object ID
202243199349330619
Schema version
2021v4.2
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2022-11-15T19:51:05-06:00ReturnTs
Tax Period End2021-12-31TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

FieldValueIRS element (for citing)
Preparer Firm EIN410746749PreparerFirmEIN

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1CLIFTONLARSONALLEN LLPBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line1TWO INTERNATIONAL PLACE 22ND FLOORAddressLine1Txt
CityBOSTONCityNm
State AbbreviationMAStateAbbreviationCd
ZIP02110ZIPCd
FieldValueIRS element (for citing)
Return Type990ReturnTypeCd
Tax Period Begin2021-01-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN521224577EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1BIOTECHNOLOGY INNOVATION ORGANIZATIONBusinessNameLine1Txt
FieldValueIRS element (for citing)
Business Name ControlBIOTBusinessNameControlTxt
Phone2029629200PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line11201 MARYLAND AVE SW NO 900AddressLine1Txt
CityWASHINGTONCityNm
State AbbreviationDCStateAbbreviationCd
ZIP20024ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonSTEPHEN JASKOPersonNm
Person TitleCFOPersonTitleTxt
Phone2029629200PhoneNum
Signature2022-11-15SignatureDt
Discuss With Paid PreparerYes (1)DiscussWithPaidPreparerInd

Signing Officer SigningOfficerGrp

Person Full Name PersonFullName

FieldValueIRS element (for citing)
Person FirstSTEPHENPersonFirstNm
Person LastJASKOPersonLastNm
FieldValueIRS element (for citing)
SSNXXX-XX-XXXXSSN

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonLAURA J KENNEYPreparerPersonNm
PTINP00202198PTIN
Phone6177170831PhoneNum
Preparation2022-11-15PreparationDt

Additional Filer Information AdditionalFilerInformation

Trusted Customer TrustedCustomerGrp

FieldValueIRS element (for citing)
Trusted Customer3TrustedCustomerCd
Authentication Assurance LevelAAL1AuthenticationAssuranceLevelCd
Identity Assurance LevelIAL1IdentityAssuranceLevelCd
FieldValueIRS element (for citing)
Tax2021TaxYr
Build TS2022-09-23 18:48:47ZBuildTS

Form 990 IRS990

FieldValueIRS element (for citing)
Principal OfficerMICHELLE MCMURRY-HEATHPrincipalOfficerNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line11201 MARYLAND AVE SW NO 900AddressLine1Txt
CityWASHINGTONCityNm
State AbbreviationDCStateAbbreviationCd
ZIP20024ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$99,740,284GrossReceiptsAmt
Group Return For Affiliates0GroupReturnForAffiliatesInd
Organization501cYes (X)Organization501cInd
Website AddressWWW.BIO.ORGWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation1993FormationYr
Legal Domicile StateDCLegalDomicileStateCd
Activity Or MissionSUPPORT THE BIOTECHNOLOGY INDUSTRY AND TO EXPAND THE BOUNDARIES OF SCIENCE TO BENEFIT MANKIND.ActivityOrMissionDesc
Voting Members Governing Body96VotingMembersGoverningBodyCnt
Voting Members Independent95VotingMembersIndependentCnt
Total Employee203TotalEmployeeCnt
Total Volunteers97TotalVolunteersCnt
Total Gross UBI$1,153,688TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm$544,386NetUnrelatedBusTxblIncmAmt
PY Contributions Grants$0PYContributionsGrantsAmt
CY Contributions Grants$154,941CYContributionsGrantsAmt
PY Program Service Revenue$41,958,016PYProgramServiceRevenueAmt
CY Program Service Revenue$52,920,414CYProgramServiceRevenueAmt
PY Investment Income$6,102,556PYInvestmentIncomeAmt
CY Investment Income$6,180,523CYInvestmentIncomeAmt
PY Other Revenue$29,218,945PYOtherRevenueAmt
CY Other Revenue$21,654,962CYOtherRevenueAmt
PY Total Revenue$77,279,517PYTotalRevenueAmt
CY Total Revenue$80,910,840CYTotalRevenueAmt
PY Grants And Similar Paid$2,976,500PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$2,103,465CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$40,492,059PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$34,982,444CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$0PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$0CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$0CYTotalFundraisingExpenseAmt
PY Other Expenses$38,376,099PYOtherExpensesAmt
CY Other Expenses$42,972,209CYOtherExpensesAmt
PY Total Expenses$81,844,658PYTotalExpensesAmt
CY Total Expenses$80,058,118CYTotalExpensesAmt
PY Revenues Less Expenses-$4,565,141PYRevenuesLessExpensesAmt
CY Revenues Less Expenses$852,722CYRevenuesLessExpensesAmt
Total Assets BOY$76,544,473TotalAssetsBOYAmt
Total Assets EOY$113,666,319TotalAssetsEOYAmt
Total Liabilities BOY$32,801,999TotalLiabilitiesBOYAmt
Total Liabilities EOY$69,410,674TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$43,742,474NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$44,255,645NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part IIIYes (X)InfoInScheduleOPartIIIInd
MissionTHE BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO) REPRESENTS APPROXIMATELY 1,000 COMPANIES AND ORGANIZATIONS IN WASHINGTON DC, STATE CAPITALS, AND INTERNATIONAL FORA. BIO IS FOUNDED ON THE PRINCIPLE THAT POLICY MUST NURTURE INNOVATION IN THE LIFE SCIENCES TO OVERCOME CHALLENGES IN HEALTH CARE, AGRICULTURE, INDUSTRY, AND THE ENVIRONMENT. OUR MEMBERS REPRESENT COMPANIES OFFERING A SPECTRUM OF BIOTECHNOLOGY APPLICATIONS ACROSS MAJOR SECTORS OF THE ECONOMY. BIO MEMBERS ALSO INCLUDE UNIVERSITIES, NONPROFITS, PATIENT GROUPS, AND OTHER ORGANIZATIONS THAT PLAY AN IMPORTANT ROLE IN THE FUTURE OF THE LIFE SCIENCES. BIO'S ACTIVITIES ARE BROKEN DOWN INTO TWO PROGRAMS - ADVOCACY AND SERVICES.MissionDesc
Significant New Program Srvc0SignificantNewProgramSrvcInd
Significant Change0SignificantChangeInd
DescADVOCACY: BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO)'S ADVOCACY EFFORTS REFLECT THE PRIORITIES IDENTIFIED BY THE BIO BOARD OF DIRECTORS AND THE FOUR SECTION GOVERNING BOARDS.THE BOARD OF DIRECTORS FOCUSES ON ISSUES OF IMPORTANCE TO ALL BIO MEMBERS, REGARDLESS OF THEIR SIZE OR TECHNOLOGY. THESE CROSS-CUTTING ADVOCACY ACCOMPLISHMENTS IN 2021 ARE LISTED BELOW: - SAFEGUARDED AND ADVANCED INTELLECTUAL PROPERTY PROTECTIONS, DOMESTICALLY AND INTERNATIONALLY.- FOSTERED A DIALOGUE ABOUT BIOETHICS AND PROACTIVELY ADVANCED THE SOCIALLY RESPONSIBLE USE OF BIOTECHNOLOGY.- PROMOTED INVESTMENT IN GOVERNMENT AND ACADEMIC RESEARCH.- EXPANDED OUTREACH TO FOREIGN GOVERNMENTS AND INTERNATIONAL ENTITIES TO EDUCATE ON POLICY ISSUES OF IMPORTANCE TO THE BIOTECHNOLOGY INDUSTRY AND TO IMPROVE THE INVESTMENT AND REGULATORY CLIMATE FOR BIOTECH PRODUCTS.THE HEALTH SECTION 2021 ADVOCACY ACCOMPLISHMENTS: - PROMOTED HEALTHCARE POLICIES THAT RECOGNIZE BOTH THE PROMISE AND VALUE OF INNOVATION.- ADVOCATED FOR A SAFE AND PREDICTABLE REGULATORY ENVIRONMENT FOR VALUE-BASED PAYMENT ARRANGEMENTS FOR DRUGS AND BIOLOGICS.- ENHANCED AND PROTECTED PATIENT ACCESS TO INNOVATIVE THERAPIES AND PROMOTED THE NEED FOR GREATER NONDISCRIMINATION ENFORCEMENT AGAINST INSURANCE BENEFIT DESIGNS.- ADVOCATED FOR BIOSIMILARS POLICIES THAT PROTECT PATIENT SAFETY, PROMOTE BIOMEDICAL INNOVATION, AND ADVANCE THE SCIENCE-BASED REVIEW AND APPROVAL OF BIOSIMILARS AND INTERCHANGEABLE BIOLOGICAL PRODUCTS.- PROMOTED THE VALUE OF U.S. GOVERNMENT INVESTMENTS IN PROGRAMS THAT IMPROVE ACCESS TO IMMUNIZATIONS AND FOSTER VACCINE INNOVATION, STRENGTHENED OUR ABILITY TO RESPOND TO BIOTERROR THREATS OR EMERGING INFECTIOUS DISEASES, AND ENCOURAGED DEVELOPMENT OF NEW PRODUCTS TO FIGHT ANTIMICROBIAL RESISTANCE (AMR).- INFLUENCED IMPROVEMENTS TO THE INTERNATIONAL ENVIRONMENT FOR BIOMEDICAL INNOVATION AND GLOBAL PUBLIC HEALTH PREPAREDNESS.-ADVOCATED FOR THE MODERNIZATION OF THE CLINICAL DEVELOPMENT PARADIGMTHE EMERGING COMPANIES SECTION 2021 ADVOCACY ACCOMPLISHMENTS: - ADVANCED THE INTEREST OF EMERGING COMPANIES IN CAPITAL FORMATION AND FINANCIAL SERVICES POLICY.- ADVOCATED FOR FISCAL POLICIES SUPPORTING INNOVATIVE EMERGING COMPANIES AND INVESTMENT IN GROUNDBREAKING R&D; ENHANCED THE VOICE OF PRE-REVENUE, R&D-INTENSIVE BUSINESSES- ADVOCATED FOR THE REMOVAL OF BURDENSOME FINANCIAL REPORTING REGULATIONS ON EMERGING COMPANIES.THE FOOD & AGRICULTURE SECTION 2021 ADVOCACY ACCOMPLISHMENTS: - WORKED WITH THE ADMINISTRATION AND CONGRESS TO ADVANCE IMPROVEMENTS TO THE U.S. AND GLOBAL REGULATORY SYSTEMS FOR AG-BIOTECH PRODUCTS. - WORKED WITH MEMBERS OF THE AGRICULTURAL VALUE CHAIN TO ADDRESS TRADE ISSUES IN AGRICULTURAL EXPORT MARKETS SUCH AS CHINA AND EUROPE. - ADVOCATED IN LEGISLATURES AND COURTS TO PRESERVE THE RIGHTS OF FARMERS TO PLANT GENETICALLY ENGINEERED CROPS. THE INDUSTRIAL & ENVIRONMENTAL SECTION 2021 ADVOCACY ACCOMPLISHMENTS: - SUPPORTED A RENEWABLE CHEMICALS REPORT.- ADVOCATED FOR EPA TO TREAT ALL SUSTAINABLY SOURCED BIOMASS AS ELIGIBLE MEASURES FOR EMISSIONS REDUCTION CREDIT (ERC) GENERATION. - ADVOCATED REGARDING THE IMPLEMENTATION OF THE TOXIC SUBSTANCES CONTROL ACT (TSCA) AS AMENDED BY CONGRESS, AS WELL AS ISSUES RELATING TO THE NATIONAL BIOENGINEERED FOOD DISCLOSURE ACT.- ENGAGED WITH THE ADMINISTRATION'S REVIEW OF THE COORDINATED FRAMEWORK FOR BIOTECHNOLOGY, INCLUDING WITH RESPECT TO THE REGULATION OF GENETICALLY ENGINEERED (GE) ALGAE.Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

FieldValueIRS element (for citing)
DescSERVICES: BIO'S SERVICES INCLUDE CONFERENCES AND ACTIVITIES THAT BRING TOGETHER INDUSTRY STAKEHOLDERS AND INVESTORS FOR EVENTS RANGING FROM THE BIO INTERNATIONAL CONVENTION TO CONFERENCES FOR BUSINESS DEVELOPMENT EXECUTIVES.THE BIO INTERNATIONAL CONVENTION ATTRACTS THE MOST INFLUENTIAL BIOTECH AND PHARMA ATTENDEES FROM 76 COUNTRIES AND 48 U.S. STATES, AS WELL AS THE DISTRICT OF COLUMBIA, PUERTO RICO AND THE US VIRGIN ISLANDS AND OFFERS PROFESSIONAL AND BUSINESS DEVELOPMENT OPPORTUNITIES. THE NET INCOME FROM THE CONVENTION SUPPORTS OUR ADVOCACY, PUBLIC OUTREACH, AND OTHER MEMBER SERVICE ACTIVITIES.THE KEY ELEMENTS OF THE BIO INTERNATIONAL CONVENTION ARE EDUCATIONAL PROGRAMMING, EXHIBITION, THE BIO BUSINESS FORUM, AND NETWORKING EVENTS. THESE ELEMENTS PROVIDE AN OPPORTUNITY FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, ACADEMIC RESEARCH INSTITUTIONS, AND INVESTORS FROM AROUND THE WORLD TO LEARN ABOUT RECENT SCIENTIFIC AND POLICY DEVELOPMENTS, AND SCHEDULE ONE-ON-ONE MEETINGS TO DISCUSS POTENTIAL BUSINESS OPPORTUNITIES. THE BIO BUSINESS FORUM AT THE CONVENTION HOSTS TENS OF THOUSANDS OF PARTNERING MEETINGS AMONG A FEW THOUSAND COMPANIES, ALONG WITH A COUPLE HUNDRED COMPANY PRESENTATIONS. THE CONVENTION HOSTS HUNDREDS OF SPEAKERS, AND OVER A THOUSAND EXHIBITIONS WITH INTERNATIONAL, REGIONAL AND STATE PAVILIONS (AND A NUMBER OF PRODUCT FOCUS ZONES).BEYOND THE CONVENTION, BIO HOSTS OR CO-HOSTS A NUMBER OF NATIONAL AND INTERNATIONAL CONFERENCES THAT PROVIDE VENUES FOR MEMBER AND NON-MEMBER COMPANIES TO PRESENT NEW DATA, MEET WITH FELLOW BIOTECH COMPANIES, AND ATTRACT FUNDING FROM INVESTORS AND OTHER ORGANIZATIONS.Desc
FieldValueIRS element (for citing)
Described In Section501c30DescribedInSection501c3Ind
Schedule B RequiredYes (1)ScheduleBRequiredInd
Political Campaign Acty0PoliticalCampaignActyInd
Subject To Proxy TaxYes (1)SubjectToProxyTaxInd
Donor Advised Fund0DonorAdvisedFundInd
Conservation Easements0ConservationEasementsInd
Collections Of Art0CollectionsOfArtInd
Credit Counseling0CreditCounselingInd
Donor Rstr Or Quasi Endowments0DonorRstrOrQuasiEndowmentsInd
Report Land Building EquipmentYes (1)ReportLandBuildingEquipmentInd
Report Investments Other Sec0ReportInvestmentsOtherSecInd
Report Program Related Invst0ReportProgramRelatedInvstInd
Report Other AssetsYes (1)ReportOtherAssetsInd
Report Other LiabilitiesYes (1)ReportOtherLiabilitiesInd
Include FIN48 Footnote0IncludeFIN48FootnoteInd
Independent Audit Fincl StmtYes (1)IndependentAuditFinclStmtInd
Consolidated Audit Fincl Stmt0ConsolidatedAuditFinclStmtInd
School Operating0SchoolOperatingInd
Foreign Office0ForeignOfficeInd
Foreign ActivitiesYes (1)ForeignActivitiesInd
More Than5000 K To OrgYes (1)MoreThan5000KToOrgInd
More Than5000 K To Individuals0MoreThan5000KToIndividualsInd
Professional Fundraising0ProfessionalFundraisingInd
Fundraising Activities0FundraisingActivitiesInd
Gaming Activities0GamingActivitiesInd
Operate Hospital0OperateHospitalInd
Grants To OrganizationsYes (1)GrantsToOrganizationsInd
Grants To Individuals0GrantsToIndividualsInd
Schedule J RequiredYes (1)ScheduleJRequiredInd
Tax Exempt Bonds0TaxExemptBondsInd
Loan Outstanding0LoanOutstandingInd
Grant To Related Person0GrantToRelatedPersonInd
Business Rln With Org Mem0BusinessRlnWithOrgMemInd
Business Rln With Fam MemYes (1)BusinessRlnWithFamMemInd
Business Rln With35 Ctrl Ent0BusinessRlnWith35CtrlEntInd
Deductible Non Cash Contri0DeductibleNonCashContriInd
Deductible Art Contribution0DeductibleArtContributionInd
Terminate Operations0TerminateOperationsInd
Partial Liquidation0PartialLiquidationInd
Disregarded Entity0DisregardedEntityInd
Related EntityYes (1)RelatedEntityInd
Related Organization Ctrl Ent0RelatedOrganizationCtrlEntInd
Activities Conducted Prtshp0ActivitiesConductedPrtshpInd
Schedule O RequiredYes (1)ScheduleORequiredInd
IRP Document129IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Backup Wthld ComplianceYes (1)BackupWthldComplianceInd
Employee203EmployeeCnt
Employment Tax Returns FiledYes (1)EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over LimitYes (1)UnrelatedBusIncmOverLimitInd
Form990 T FiledYes (1)Form990TFiledInd
Foreign Financial AccountYes (1)ForeignFinancialAccountInd
Foreign CountryINForeignCountryCd
Prohibited Tax Shelter Trans0ProhibitedTaxShelterTransInd
Taxable Party Notification0TaxablePartyNotificationInd
Nondeductible ContributionsYes (1)NondeductibleContributionsInd
Nondeductible Contri Discl0NondeductibleContriDisclInd
Indoor Tanning Services0IndoorTanningServicesInd
Subj To Tax Rmnrtn Ex Prcht PymtYes (1)SubjToTaxRmnrtnExPrchtPymtInd
Subject To Excs Tax Net Invst Inc0SubjectToExcsTaxNetInvstIncInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members96GoverningBodyVotingMembersCnt
Independent Voting Member95IndependentVotingMemberCnt
Family Or Business Rln0FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties0DelegationOfMgmtDutiesInd
Change To Org Documents0ChangeToOrgDocumentsInd
Material Diversion Or Misuse0MaterialDiversionOrMisuseInd
Members Or StockholdersYes (1)MembersOrStockholdersInd
Election Of Board MembersYes (1)ElectionOfBoardMembersInd
Decisions Subject To Approva0DecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (1)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (1)MinutesOfCommitteesInd
Officer Mailing Address0OfficerMailingAddressInd
Local Chapters0LocalChaptersInd
Form990 Provided To Gvrn Body0Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (1)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (1)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (1)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (1)WhistleblowerPolicyInd
Document Retention PolicyYes (1)DocumentRetentionPolicyInd
Compensation Process CEOYes (1)CompensationProcessCEOInd
Compensation Process OtherYes (1)CompensationProcessOtherInd
Investment In Joint Venture0InvestmentInJointVentureInd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

FieldValueIRS element (for citing)
PersonSTEPHEN JASKOPersonNm
Phone2029629200PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line11201 NEW YORK AVE NW SUITE 1300AddressLine1Txt
CityWASHINGTONCityNm
State AbbreviationDCStateAbbreviationCd
ZIP20005ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (135 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtIndividual Trustee Or DirectorIndividualTrusteeOrDirectorIndOfficerOfficerIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmtKey EmployeeKeyEmployeeIndHighest Compensated EmployeeHighestCompensatedEmployeeInd
JULIE GERBERDING
SECRETARY2.00Yes (X)Yes (X)$0$0$0
JEREMY LEVIN
IMMEDIATE PAST CHAIR2.00Yes (X)Yes (X)$0$0$0
ELIZABETH LEWIS
SECRETARY2.00Yes (X)Yes (X)$0$0$0
JOHN MARAGANORE
IMMEDIATE PAST CHAIR2.00Yes (X)Yes (X)$0$0$0
HELEN TORLEY UNTIL 121
SECRETARY2.00Yes (X)Yes (X)$0$0$0
BRADFORD ZAKES
TREASURER2.00Yes (X)Yes (X)$0$0$0
STEVE ALBERS
DIRECTOR2.00Yes (X)$0$0$0
ANNE ALONZO UNTIL 921
DIRECTOR2.00Yes (X)$0$0$0
BONNIE ANDERSON
DIRECTOR2.00Yes (X)$0$0$0
STUART ARBUCKLE
DIRECTOR2.00Yes (X)$0$0$0
MARTIN BABLER
DIRECTOR2.00Yes (X)$0$0$0
DUANE BARNES UNTIL 121
DIRECTOR2.00Yes (X)$0$0$0
LAURA BEREZIN UNTIL 121
DIRECTOR2.00Yes (X)$0$0$0
DOUG BERVEN
DIRECTOR2.00Yes (X)$0$0$0
JEAN-JACQUES BIENAIME
DIRECTOR2.00Yes (X)$0$0$0
FRITZ BITTENBENDER
DIRECTOR2.00Yes (X)$0$0$0
CHRISTOPHER BOERNER
DIRECTOR2.00Yes (X)$0$0$0
CHRISTOPHE BOURDON UNTIL 321
DIRECTOR2.00Yes (X)$0$0$0
CARRIE BOURDOW
DIRECTOR2.00Yes (X)$0$0$0
CARINE BOUSTANY
DIRECTOR2.00Yes (X)$0$0$0
BRIAN BRAZEAU UNTIL 821
DIRECTOR2.00Yes (X)$0$0$0
STEPHANIE BROWN UNTIL 1121
DIRECTOR2.00Yes (X)$0$0$0
VICTOR BULTO
DIRECTOR2.00Yes (X)$0$0$0
EMMANUEL CAEYMAEX
DIRECTOR2.00Yes (X)$0$0$0
KAY CHANDLER
DIRECTOR2.00Yes (X)$0$0$0
IVAN CHEUNG
DIRECTOR2.00Yes (X)$0$0$0
MEENU CHHABRA KASON UNTIL 321
DIRECTOR2.00Yes (X)$0$0$0
GIACOMO CHIESI
DIRECTOR2.00Yes (X)$0$0$0
JEFFREY CLELAND
DIRECTOR2.00Yes (X)$0$0$0
RON COHEN
DIRECTOR2.00Yes (X)$0$0$0
GRACE COLON
DIRECTOR2.00Yes (X)$0$0$0
BRUCE COZADD
DIRECTOR2.00Yes (X)$0$0$0
JOHN CROWLEY
DIRECTOR2.00Yes (X)$0$0$0
ROGER CRYSTAL
DIRECTOR2.00Yes (X)$0$0$0
DOUGLAS DOERFLER
DIRECTOR2.00Yes (X)$0$0$0
MARK DROZDOWSKI UNTIL 621
DIRECTOR2.00Yes (X)$0$0$0
ERIC DUBE
DIRECTOR2.00Yes (X)$0$0$0
MARK ENYEDY
DIRECTOR2.00Yes (X)$0$0$0
BARRY FLANNELLY
DIRECTOR2.00Yes (X)$0$0$0
ALEXANDRIA FORBES
DIRECTOR2.00Yes (X)$0$0$0
CEDRIC FRANCOIS
DIRECTOR2.00Yes (X)$0$0$0
BRIAN GOFF UNTIL 721
DIRECTOR2.00Yes (X)$0$0$0
KEVIN GORMAN
DIRECTOR2.00Yes (X)$0$0$0
JUSTIN GOVER UNTIL 521
DIRECTOR2.00Yes (X)$0$0$0
PATRICK GRUBER
DIRECTOR2.00Yes (X)$0$0$0
CHIRFI GUINDO
DIRECTOR2.00Yes (X)$0$0$0
SEBASTIAN GUTH
DIRECTOR2.00Yes (X)$0$0$0
STEVEN HARR
DIRECTOR2.00Yes (X)$0$0$0
PAUL HASTINGS
DIRECTOR2.00Yes (X)$0$0$0
RACHEL HAURWITZ
DIRECTOR2.00Yes (X)$0$0$0
CHRISTOPHER HEALEY
DIRECTOR2.00Yes (X)$0$0$0
JENNIFER HOLMGREN
DIRECTOR2.00Yes (X)$0$0$0
SCOTT HOLMSTROM UNTIL 921
DIRECTOR2.00Yes (X)$0$0$0
PATRIK JONSSON
DIRECTOR2.00Yes (X)$0$0$0
ALEX KARNAL
DIRECTOR2.00Yes (X)$0$0$0
DANIEL KEIL
DIRECTOR2.00Yes (X)$0$0$0
DAVID KETTNER
DIRECTOR2.00Yes (X)$0$0$0
JEFFREY KINDLER UNTIL 621
DIRECTOR2.00Yes (X)$0$0$0
RACHEL KING
DIRECTOR2.00Yes (X)$0$0$0
SCOTT KOENIG
DIRECTOR2.00Yes (X)$0$0$0
SAMARTH KULKARNI
DIRECTOR2.00Yes (X)$0$0$0
JOSEPH LAROSA
DIRECTOR2.00Yes (X)$0$0$0
JOHN LEPORE
DIRECTOR2.00Yes (X)$0$0$0
NICK LESCHLY UNTIL 1221
DIRECTOR2.00Yes (X)$0$0$0
TED LOVE
DIRECTOR2.00Yes (X)$0$0$0
SANDY MACRAE
DIRECTOR2.00Yes (X)$0$0$0
GAIL MADERIS
DIRECTOR2.00Yes (X)$0$0$0
PAIGE MAHANEY UNTIL 521
DIRECTOR2.00Yes (X)$0$0$0
AAMIR MALIK
DIRECTOR2.00Yes (X)$0$0$0
AMEET MALLIK UNTIL 421
DIRECTOR2.00Yes (X)$0$0$0
SHARON MATES
DIRECTOR2.00Yes (X)$0$0$0
THOMAS MATHERS
DIRECTOR2.00Yes (X)$0$0$0
JOHN MELO
DIRECTOR2.00Yes (X)$0$0$0
BOB MORE
DIRECTOR2.00Yes (X)$0$0$0
MICHAEL MORRISSEY
DIRECTOR2.00Yes (X)$0$0$0
MICHAEL NARACHI
DIRECTOR2.00Yes (X)$0$0$0
AMIR NASHAT
DIRECTOR2.00Yes (X)$0$0$0
WILLIAM NEWELL
DIRECTOR2.00Yes (X)$0$0$0
JULIA OWENS
DIRECTOR2.00Yes (X)$0$0$0
JOHN OYLER
DIRECTOR2.00Yes (X)$0$0$0
RICHARD PAULSON UNTIL 521
DIRECTOR2.00Yes (X)$0$0$0
ADELENE PERKINS
DIRECTOR2.00Yes (X)$0$0$0
MARK PLATT
DIRECTOR2.00Yes (X)$0$0$0
RICHARD POPS
DIRECTOR2.00Yes (X)$0$0$0
MARK PRUZANSKI
DIRECTOR2.00Yes (X)$0$0$0
SOFIE QIAO
DIRECTOR2.00Yes (X)$0$0$0
MICHAEL RAAB
DIRECTOR2.00Yes (X)$0$0$0
ANNA RATH
DIRECTOR2.00Yes (X)$0$0$0
ELENA RICE
DIRECTOR2.00Yes (X)$0$0$0
HOWARD ROBIN
DIRECTOR2.00Yes (X)$0$0$0
MICHAEL RUGGIERO
DIRECTOR2.00Yes (X)$0$0$0
AMBER SALZMAN UNTIL 621
DIRECTOR2.00Yes (X)$0$0$0
JAMES SAPIRSTEIN
DIRECTOR2.00Yes (X)$0$0$0
GEORGE SCANGOS UNTIL 621
DIRECTOR2.00Yes (X)$0$0$0
CHRISTOPHE SCHILLING
DIRECTOR2.00Yes (X)$0$0$0
DIANE SHANAHAN UNTIL 921
DIRECTOR2.00Yes (X)$0$0$0
CHRISTI SHAW
DIRECTOR2.00Yes (X)$0$0$0
JEFFREY SHERMAN
DIRECTOR2.00Yes (X)$0$0$0
BILL SIBOLD
DIRECTOR2.00Yes (X)$0$0$0
NANCY SIMONIAN
DIRECTOR2.00Yes (X)$0$0$0
DUANE SIMPSON
DIRECTOR2.00Yes (X)$0$0$0
ERIKA SMITH
DIRECTOR2.00Yes (X)$0$0$0
JULIE ANNE SMITH UNTIL 821
DIRECTOR2.00Yes (X)$0$0$0
ELAINE SORG
DIRECTOR2.00Yes (X)$0$0$0
CHRISTOPHER STANDLEE UNTIL 121
DIRECTOR2.00Yes (X)$0$0$0
EDDIE SULLIVAN
DIRECTOR2.00Yes (X)$0$0$0
JENNIFER TAUBERT UNTIL 121
DIRECTOR2.00Yes (X)$0$0$0
IAN THOMPSON
DIRECTOR2.00Yes (X)$0$0$0
LINDA TROLINDER
DIRECTOR2.00Yes (X)$0$0$0
MARK TRUDEAU
DIRECTOR2.00Yes (X)$0$0$0
RICK TURNER UNTIL 1121
DIRECTOR2.00Yes (X)$0$0$0
GIL VAN BOKKELEN UNTIL 521
DIRECTOR2.00Yes (X)$0$0$0
TIMOTHY WALBERT UNTIL 521
DIRECTOR2.00Yes (X)$0$0$0
OLIVER WALKER
DIRECTOR2.00Yes (X)$0$0$0
HENRIK WAREBORN
DIRECTOR2.00Yes (X)$0$0$0
NEIL WARMA
DIRECTOR2.00Yes (X)$0$0$0
SUE WASHER
DIRECTOR2.00Yes (X)$0$0$0
FRANK WATANABE
DIRECTOR2.00Yes (X)$0$0$0
ANNE WHITE UNTIL 1021
DIRECTOR2.00Yes (X)$0$0$0
SCOTT WHITE
DIRECTOR2.00Yes (X)$0$0$0
ROBERT WILLS UNTIL 621
DIRECTOR2.00Yes (X)$0$0$0
RICK WINNINGHAM
DIRECTOR2.00Yes (X)$0$0$0
SYLVIA WULF
DIRECTOR2.00Yes (X)$0$0$0
ROGER WYSE
DIRECTOR2.00Yes (X)$0$0$0
JOHN YOUNG UNTIL 1221
DIRECTOR2.00Yes (X)$0$0$0
BERNHARDT ZEIHER UNTIL 321
DIRECTOR2.00Yes (X)$0$0$0
JILL ZULLO
DIRECTOR2.00Yes (X)$0$0$0
MICHELLE MCMURRY-HEATH
PRESIDENT AND CEO40.00Yes (X)$2,050,133$0$264,622
STEPHEN JASKO
CHIEF FINANCIAL OFFICER40.00Yes (X)$506,022$0$33,551
THOMAS DILENGE
PRESIDENT, ADVOCACY/LAW/PUBLIC POLICY40.00$1,355,976$0$39,096Yes (X)
RICH MASTERS
CHIEF PUBLIC AFFAIRS OFFICER40.00$643,726$0$45,694Yes (X)
ELIZABETH ESHAM
CHIEF SCIENCE OFFICER40.00$605,569$0$43,889Yes (X)
PETER MCHUGH
CHIEF LEGAL OFFICER40.00$558,879$0$56,671Yes (X)
JOSEPH DAMOND
DEPUTY CHIEF POLICY OFFICER & EVP INTERNATIONAL AF40.00$533,658$0$77,891Yes (X)
SHAYE MANDLE
COO40.00$522,185$0$33,551Yes (X)
FieldValueIRS element (for citing)
Total Reportable Comp From Org$6,776,148TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$0TotReportableCompRltdOrgAmt
Total Other Compensation$594,965TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K97IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed0FormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (1)TotalCompGreaterThan150KInd
Compensation From Other Srcs0CompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (5 entries)

Address Line1ContractorAddress/USAddress/AddressLine1TxtCityContractorAddress/USAddress/CityNmState AbbreviationContractorAddress/USAddress/StateAbbreviationCdZIPContractorAddress/USAddress/ZIPCdServicesServicesDescCompensationCompensationAmt
THE HERALD GROUP LLC
1800 M STREET NW SUITE 450 SOUTHWASHINGTONDC20036CONVENTION CENTER RENTAL$2,100,000
SIDLEY AUSTIN LLP
PO BOX 0642CHICAGOIL60690CONSULTING$1,247,540
PUBLIC GOOD PROJECTS
2308 MOUNT VERNON AVENUE SUITE 758ALEXANDRIAVA22301CONSULTING$883,000
KEYBRIDGE COMMUNICATIONS
1722-A WISCONSIN AVENUE NW SUITE 2WASHINGTONDC20007CONSULTING$879,787
360 LIVE MEDIA LLC
2001 K STREET NW 3RD FLOOR NORTHWASHINGTONDC20006CONSULTING$832,500
FieldValueIRS element (for citing)
Cntrct Rcvd Greater Than100 K61CntrctRcvdGreaterThan100KCnt
All Other Contributions$154,941AllOtherContributionsAmt
Total Contributions$154,941TotalContributionsAmt

Program Service Revenue ProgramServiceRevenueGrp (5 entries)

DescDescBusinessBusinessCdTotal Revenue ColumnTotalRevenueColumnAmtRelated Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmtUnrelated Business RevenueUnrelatedBusinessRevenueAmt
MEMBERSHIP DUES900003$32,415,003$32,415,003
CONFERENCE/MEETING REVENUE541800$11,316,867$10,939,822$377,045
SPECIAL INITIATIVES900003$7,457,234$7,457,234
CBI LOBBYING FUND900003$1,062,280$1,062,280
LEGAL & POLICY SUPPORT900003$533,218$533,218

Total Oth Program Service Rev TotalOthProgramServiceRevGrp

FieldValueIRS element (for citing)
Total Revenue Column$135,812TotalRevenueColumnAmt
Related Or Exempt Func Income$135,812RelatedOrExemptFuncIncomeAmt
FieldValueIRS element (for citing)
Total Program Service Revenue$52,920,414TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$1,939,051TotalRevenueColumnAmt
Exclusion$1,939,051ExclusionAmt

Royalties Revenue RoyaltiesRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$19,182,040TotalRevenueColumnAmt
Unrelated Business Revenue$766,643UnrelatedBusinessRevenueAmt
Exclusion$18,415,397ExclusionAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

FieldValueIRS element (for citing)
Securities$23,070,916SecuritiesAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

FieldValueIRS element (for citing)
Securities$18,829,444SecuritiesAmt

Gain Or Loss GainOrLossGrp

FieldValueIRS element (for citing)
Securities$4,241,472SecuritiesAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

FieldValueIRS element (for citing)
Total Revenue Column$4,241,472TotalRevenueColumnAmt
Exclusion$4,241,472ExclusionAmt

Other Revenue Misc OtherRevenueMiscGrp (3 entries)

DescDescBusinessBusinessCdTotal Revenue ColumnTotalRevenueColumnAmtExclusionExclusionAmtUnrelated Business RevenueUnrelatedBusinessRevenueAmt
INSURANCE CLAIMS REVENUE524298$2,373,400$2,373,400
TAX REFUND900003$89,522$89,522
BIONEWS ADS INCOME900003$10,000$10,000
FieldValueIRS element (for citing)
Other Revenue Total$2,472,922OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$80,910,840TotalRevenueColumnAmt
Related Or Exempt Func Income$52,543,369RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$1,153,688UnrelatedBusinessRevenueAmt
Exclusion$27,058,842ExclusionAmt
FieldValueIRS element (for citing)
Info In Schedule O Part IXYes (X)InfoInScheduleOPartIXInd

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

FieldValueIRS element (for citing)
Total$2,097,401TotalAmt

Foreign Grants ForeignGrantsGrp

FieldValueIRS element (for citing)
Total$6,064TotalAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$7,466,183TotalAmt

Comp Disqual Persons CompDisqualPersonsGrp

FieldValueIRS element (for citing)
Total$28,315TotalAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$22,960,292TotalAmt

Pension Plan Contributions PensionPlanContributionsGrp

FieldValueIRS element (for citing)
Total$90,132TotalAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$3,113,155TotalAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$1,324,367TotalAmt

Fees For Services Legal FeesForServicesLegalGrp

FieldValueIRS element (for citing)
Total$458,376TotalAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$78,271TotalAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

FieldValueIRS element (for citing)
Total$5,204,776TotalAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

FieldValueIRS element (for citing)
Total$48,027TotalAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$13,011,664TotalAmt

Advertising AdvertisingGrp

FieldValueIRS element (for citing)
Total$1,392,500TotalAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$490,851TotalAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$1,178,794TotalAmt

Occupancy OccupancyGrp

FieldValueIRS element (for citing)
Total$6,940,556TotalAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$492,326TotalAmt

Conferences Meetings ConferencesMeetingsGrp

FieldValueIRS element (for citing)
Total$3,846,620TotalAmt

Interest InterestGrp

FieldValueIRS element (for citing)
Total$1,380TotalAmt

Payments To Affiliates PaymentsToAffiliatesGrp

FieldValueIRS element (for citing)
Total$8,147,829TotalAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$518,945TotalAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$170,219TotalAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDescTotalTotalAmt
DUES & SUBSCRIPTIONS$339,980
TAXES PAID$338,787
OUTREACH$264,890
BIO LEGISLATIVE DAY/FLY$38,940

All Other Expenses AllOtherExpensesGrp

FieldValueIRS element (for citing)
Total$8,478TotalAmt

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$80,058,118TotalAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
BOY$15,487,112BOYAmt
EOY$8,880,294EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$967,224BOYAmt
EOY$4,248,582EOYAmt

Accounts Receivable AccountsReceivableGrp

FieldValueIRS element (for citing)
BOY$4,288,721BOYAmt
EOY$5,336,669EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$2,624,031BOYAmt
EOY$3,636,584EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$19,151,472LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$8,092,576LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$776,734BOYAmt
EOY$11,058,896EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

FieldValueIRS element (for citing)
BOY$52,400,651BOYAmt
EOY$52,911,446EOYAmt

Other Assets Total OtherAssetsTotalGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$27,593,848EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$76,544,473BOYAmt
EOY$113,666,319EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$18,997,300BOYAmt
EOY$18,109,640EOYAmt

Deferred Revenue DeferredRevenueGrp

FieldValueIRS element (for citing)
BOY$12,264,522BOYAmt
EOY$10,845,666EOYAmt

Other Liabilities OtherLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$1,540,177BOYAmt
EOY$40,455,368EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$32,801,999BOYAmt
EOY$69,410,674EOYAmt
FieldValueIRS element (for citing)
Organization Follows FASB117Yes (X)OrganizationFollowsFASB117Ind

No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$43,742,474BOYAmt
EOY$44,255,645EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$43,742,474BOYAmt
EOY$44,255,645EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$76,544,473BOYAmt
EOY$113,666,319EOYAmt
FieldValueIRS element (for citing)
Reconcilation Revenue Expnss$852,722ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst-$339,551NetUnrlzdGainsLossesInvstAmt
Other Changes In Net Assets$0OtherChangesInNetAssetsAmt
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or Review0AccountantCompileOrReviewInd
FS AuditedYes (1)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Separate Basis Fincl StmtYes (X)SeparateBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit CommitteeYes (1)AuditCommitteeInd
Federal Grant Audit Required0FederalGrantAuditRequiredInd

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

FieldValueIRS element (for citing)
ContributorRESTRICTEDContributorNum

Contributor Business Name ContributorBusinessName

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor US Address ContributorUSAddress

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Total ContributionsRESTRICTEDTotalContributionsAmt

Schedule C IRS990ScheduleC

FieldValueIRS element (for citing)
Substantially All Dues Nonded0SubstantiallyAllDuesNondedInd
Only In House Lobbying0OnlyInHouseLobbyingInd
Agree Carryover Prior YearYes (1)AgreeCarryoverPriorYearInd
Dues Assessments$32,415,003DuesAssessmentsAmt
Non Deductible Lbbyng Pltcl CY$10,444,118NonDeductibleLbbyngPltclCYAmt
Non Ded Lbbyng Pltcl Cyov$305,942NonDedLbbyngPltclCyovAmt
Non Deductible Lbbyng Pltcl Tot$10,750,060NonDeductibleLbbyngPltclTotAmt
Aggregate Reported Dues Ntc$13,290,151AggregateReportedDuesNtcAmt
Taxable-$2,540,091TaxableAmt

Schedule D IRS990ScheduleD

Leasehold Improvements LeaseholdImprovementsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$17,146,255OtherCostOrOtherBasisAmt
Depreciation$6,235,809DepreciationAmt
Book Value$10,910,446BookValueAmt

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$276,745OtherCostOrOtherBasisAmt
Depreciation$276,746DepreciationAmt
Book Value-$1BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$1,728,472OtherCostOrOtherBasisAmt
Depreciation$1,580,021DepreciationAmt
Book Value$148,451BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$11,058,896TotalBookValueLandBuildingsAmt

Other Assets Org OtherAssetsOrgGrp

FieldValueIRS element (for citing)
DescRIGHT OF USE ASSET - OPERATINGDesc
Book Value$27,593,848BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Other Assets$27,593,848TotalBookValueOtherAssetsAmt

Other Liabilities Org OtherLiabilitiesOrgGrp (2 entries)

DescDescAmtAmt
LEASE LIABILITY - OPERATING$40,194,879
BIO-PAC$260,489
FieldValueIRS element (for citing)
Total Liability$40,455,368TotalLiabilityAmt
Total Rev Etc Audited Fincl Stmt$80,523,262TotalRevEtcAuditedFinclStmtAmt
Net Unrealized Gains Invst-$339,551NetUnrealizedGainsInvstAmt
Revenue Not Reported-$339,551RevenueNotReportedAmt
Revenue Subtotal$80,862,813RevenueSubtotalAmt
Investment Expenses Not Incld$48,027InvestmentExpensesNotIncldAmt
Revenue Not Reported Fincl Stmt$48,027RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990$80,910,840TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt$80,010,091TotExpnsEtcAuditedFinclStmtAmt
Expenses Not Reported$0ExpensesNotReportedAmt
Expenses Subtotal$80,010,091ExpensesSubtotalAmt
Investment Expenses Not Incld2$48,027InvestmentExpensesNotIncld2Amt
Expenses Not Rpt Fincl Stmt$48,027ExpensesNotRptFinclStmtAmt
Total Expenses Per Form990$80,058,118TotalExpensesPerForm990Amt

Schedule F IRS990ScheduleF

FieldValueIRS element (for citing)
Grant Records MaintainedYes (1)GrantRecordsMaintainedInd

Account Activities Outside US AccountActivitiesOutsideUSGrp (3 entries)

RegionRegionTxtType Of Activities ConductedTypeOfActivitiesConductedTxtSpecific Services ProvidedSpecificServicesProvidedTxtRegion Total ExpendituresRegionTotalExpendituresAmt
EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUMGRANT-MAKINGCONFERENCES, ADVOCACY AND EDUCATION$6,064
SUB-SAHARAN AFRICA - ANGOLA, BENIN, BOTSWANA, BURKINA FASO,PROGRAM SERVICESADVOCACY$18,389
EUROPE (INCLUDING ICELAND & GREENLAND)PROGRAM SERVICESADVOCACY$145,071
FieldValueIRS element (for citing)
Subtotal Offices0SubtotalOfficesCnt
Subtotal Employees0SubtotalEmployeesCnt
Continuation Total Office0ContinuationTotalOfficeCnt
Continuation Total Employee0ContinuationTotalEmployeeCnt
Total Office0TotalOfficeCnt
Total Employee0TotalEmployeeCnt
Subtotal Spent$169,524SubtotalSpentAmt
Continuation Spent$0ContinuationSpentAmt
Total Spent$169,524TotalSpentAmt

Grants To Org Outside US GrantsToOrgOutsideUSGrp

FieldValueIRS element (for citing)
RegionEUROPE (INCLUDING ICELAND & GREENLAND)RegionTxt
Purpose Of GrantCONTRIBUTIONPurposeOfGrantTxt
Cash Grant$6,064CashGrantAmt
Manner Of Cash DisbursementWIRE TRANSFERMannerOfCashDisbursementTxt
Non Cash Assistance$0NonCashAssistanceAmt
FieldValueIRS element (for citing)
Total501c3 Org1Total501c3OrgCnt
Transfer To Foreign Corp0TransferToForeignCorpInd
Interest In Foreign Trust0InterestInForeignTrustInd
Foreign Corp Ownership0ForeignCorpOwnershipInd
Passive Foreign Investmest Co0PassiveForeignInvestmestCoInd
Foreign Partnership0ForeignPartnershipInd
Boycott Countries0BoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
PART I, LINE 2:THE ORGANIZATION HAS SUPPORTING DOCUMENTATION FOR THE AMOUNT THAT IS INVOICED FROM THE COMPANIES.
PART III ACCOUNTING METHOD:

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Grant Records MaintainedYes (1)GrantRecordsMaintainedInd

Recipient Table RecipientTable (80 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdRecipient EINRecipientEINIRC SectionIRCSectionDescCash GrantCashGrantAmtNon Cash AssistanceNonCashAssistanceAmtPurpose Of GrantPurposeOfGrantTxtAddress Line2USAddress/AddressLine2Txt
ALLIANCE FOR AGING RESEARCH
1700 K STREET NW SUITE 740WASHINGTONDC20006541379174501(C)(3)$15,000$0SPONSORSHIP
ALLIANCE TO PROTECT MEDICAL INNOVATION
1220 L ST NW SUITE 100 488WASHINGTONDC20005831354631501(C)(4)$50,000$0CONTRIBUTION
AMERICAN BONE HEALTH
4208 SIX FORKS RD SUITE 1000RALEIGHNC27609931022954501(C)(3)$10,000$0SUPPORT
AMERICAN BRAIN COALITION
PO BOX 1549MAPLE GROVEMN55311201852597501(C)(3)$10,000$0SUPPORT
AMERICAN CANCER SOCIETY ACTION NETWORK INC
555 11TH STREET SUITE 300WASHINGTONDC20004522340031501(C)(4)$25,000$0SPONSORSHIP
AMERICAN LUNG ASSOCIATION
55 W WACKER DRIVE SUITE 1150CHICAGOIL60601131632524501(C)(3)$15,000$0SUPPORT
ARTHRITIS FOUNDATION INC
1355 PEACHTREE ST 600ATLANTAGA30309581341679501(C)(3)$15,000$0SUPPORT
ASIAN AND PACIFIC ISLANDER AMERICAN HEALTH FORUM
ONE KAISER PLAZA SUITE 850OAKLANDCA94612943030866501(C)(3)$20,000$0GIFT/SUPPORT
ASSOCIATION OF ASIAN PACIFIC COMMUNITY HEALTH ORGANIZATIONS
2140 SHATTUCK AVE SUITE 203BERKELEYCA94704943050247501(C)(3)$60,000$0GIFT
BIONJ INC
1255 WHITEHORSE-MERCERVILLE RDTRENTONNJ08619223284393501(C)(6)$45,000$0SPONSORSHIPBUILDING B - SUITE 514
BIOUTAH
PO BOX 58531SALT LAKE CITYUT84158900899204501(C)(6)$6,500$0SUPPORT
CALIFORNIA LIFE SCIENCES ASSOCIATION
9191 TOWNE CENTRE DRIVE SUITE 450SAN DIEGOCA92122473226523501(C)(6)$200,000$0SUPPORT
CANCER SUPPORT COMMUNITY
734 15TH STREET NW SUITE 300WASHINGTONDC20005954163931501(C)(3)$30,000$0SUPPORT
CAPITAL CLUBHOUSE INC
1517 18TH ST NWWASHINGTONDC20036454366185501(C)(3)$15,000$0SUPPORT
CENTER FOR FOOD INTEGRITY
2900 NE BROOKTREE LANE SUITE 200GLADSTONEMO64119204662713501(C)(4)$50,000$0SPONSORSHIP
CENTER FORWARD
1214A INGLESIDE AVEMCLEANVA22101272429741501(C)(4)$35,000$02021 ANNUAL STAKEHOLDER PROGRAM
COLORADO BIOSCIENCE ASSOCIATION
600 GRANT STREET SUITE 306DENVERCO80203841363258501(C)(6)$15,000$0SPONSORSHIP
COMMUNITY LIVER ALLIANCE
100 W STATION SQUARE DR SUITE 1945PITTSBURGHPA15219461909171501(C)(3)$15,000$0SUPPORT
COPD FOUNDATION INC
3300 PONCE DE LEON BLVDMIAMIFL33134201048322501(C)(3)$15,000$0SUPPORT
CYSTIC FIBROSIS RESEARCH FUND INC
100 ST GEORGES RD UNIT G1ARDMOREPA19003453768161501(C)(3)$10,000$0SUPPORT
DELAWARE BIOSCIENCE ASSOCIATION
1 INNOVATION WAY SUITE 300NEWARKDE19711204147195501(C)(6)$8,000$0SUPPORT
DEPRESSION AND BIPOLAR SUPPORT ALLIANCE
55 E JACKSON BLVD SUITE 490CHICAGOIL60604363379124501(C)(3)$10,000$0SUPPORT
DUP15Q ALLIANCE
1207 LINDEN AVEPARK RIDGEIL60068200751232501(C)(3)$10,000$0SUPPORT
EPILEPSY FOUNDATION
8301 PROFESSIONAL PLACE EAST SUITELANDOVERMD20785520856660501(C)(3)$15,000$0SUPPORT200
EVERYLIFE FOUNDATION FOR RARE DISEASES
1012 14TH ST NW SUITE 500WASHINGTONDC20005264614274501(C)(3)$50,000$0SUPPORT/CONTRIBUTION
FARMERS ALLIANCE FOR INTEGRATED RESOURCES
1260 COUNTY ROAD 20 1/2LONGMONTCO80504454591729501(C)(5)$20,000$0SUPPORT
FATTY LIVER FOUNDATION
3938 E SHADY GLEN CTBOISEID83706814492542501(C)(3)$10,000$0SUPPORT
FOUNDATION FOR SARCOIDOSIS RESEARCH
1820 WEST WEBSTER AVENUE SUITE 304CHICAGOIL60614364378232501(C)(3)$16,500$0SUPPORT
GENETIC ALLIANCE
4301 CONNECTICUT AVENUE NW SUITEWASHINGTONDC20008521571905501(C)(3)$15,000$0SUPPORT404
GEORGE MASON UNIVERSITY FOUNDATION INC
3301 FAIRFAX DRIVE MSN 1G3ARLINGTONVA22201541603842501(C)(3)$10,000$0DONATION
GEORGIA BIO
999 PEACHTREE AVE NEATLANTAGA30309581849665501(C)(3)$15,000$0SPONSORSHIP
GLOBAL DOWN SYNDROME FOUNDATION
3239 E 2ND AVEDENVERCO80206264431001501(C)(3)$6,000$0SUPPORT
GO2 FOUNDATION FOR LUNG CANCER
1100 INDUSTRIAL ROAD SUITE 1SAN CARLOSCA94070204417327501(C)(3)$10,000$0SUPPORT
HAWAII CROP IMPROVEMENT ASSOCIATION
PO BOX 126AIEAHI96701990258882501(C)(6)$25,000$0SUPPORT
HEALTHYWOMEN
1 HARDING RD SUITE 102ARED BANKNJ77010521624846501(C)(3)$8,500$0SUPPORT
HEPATITIS B FOUNDATION
3805 OLD EASTON ROADDOYLESTOWNPA18902232655669501(C)(3)$15,000$0SUPPORT
HIV AND HEPATITIS POLICY INSTITUTE
1602B BELMONT ST NWWASHINGTONDC20009844147678501(C)(3)$7,500$0SUPPORT
HUNTER'S HOPE FOUNDATION INC
PO BOX 643 6368 W QUAKERORCHARD PARKNY14127161552315501(C)(3)$15,000$0SUPPORT
INFORMATION TECHNOLOGY AND INNOVATION FOUNDATION
700 K ST NW SUITE 600WASHINGTONDC20001204403497501(C)(3)$30,000$0SUPPORT
LIFE SCIENCE WASHINGTON
1551 EASTLAKE AVE E SUITE 300SEATTLEWA98102911453398501(C)(6)$10,000$0SUPPORT
LITTLE HERCULES FOUNDATION
5522 AVERY RDDUBLINOH43016461427334501(C)(3)$15,000$0SUPPORT
LULAC INSTITUTE INC
1133 19TH ST NW SUITE 1000WASHINGTONDC20036522072106501(C)(3)$150,000$0GIFT
LUPUS FOUNDATION OF AMERICA INC
2121 K STREET NW SUITE 200WASHINGTONDC20037431131436501(C)(3)$7,500$0SPONSORSHIP
LUPUS RESEARCH ALLIANCE INC
275 MADISON AVE 10TH FLOORNEW YORKNY10016582492929501(C)(3)$15,000$0SUPPORT
MASSACHUSETTS BIOTECH COUNCIL
300 TECHNOLOGY SQUARE 5TH FLOORCAMBRIDGEMA02139222693047501(C)(6)$6,000$0SPONSORSHIP
MONTANA BIOSCIENCE ALLIANCE
P O BOX 1773BILLINGSMT59106201647600501(C)(3)$20,000$0SUPPORT
NATIONAL ALLIANCE ON MENTAL ILLNESS
3803 N FAIFAX DR SUITE 100ARLINGTONVA22203431201653501(C)(3)$15,000$0SUPPORT
NATIONAL BLACK CHURCH INITIATIVE
POBOX 65177WASHINGTONDC20035522169774501(C)(3)$91,400$0SUPPORT/GIFT
NATIONAL BLOOD CLOT ALLIANCE
PO BOX 825687PHILADELPHIAPA19182562425135501(C)(3)$10,000$0SUPPORT
NATIONAL CAUCUS AND CENTER ON BACK AGING
1220 L ST NW SUITE 800WASHINGTONDC20005237455377501(C)(3)$30,000$0SUPPORT
NATIONAL CONFERENCE OF STATE LEGISLATURES
7700 EAST FIRST PLACEDENVERCO80230840772595170(C)(1)$10,000$0SPONSORSHIP
NATIONAL COUNCIL OF ASIAN PACIFIC ISLANDER PHYSICIANS
2144 BEACH STREETSAN FRANCISCOCA94123273429376501(C)(3)$50,000$0SUPPORT
NATIONAL COUNCIL ON AGING
251 18TH ST SOUTH SUITE 500ARLINGTONVA22202131932384501(C)(3)$45,000$0SPONSORSHIP
NATIONAL HEALTH COUNCIL
1730 M STREET NW SUITE 500WASHINGTONDC20036131624107501(C)(3)$49,000$0SPONSORSHIP
NATIONAL HISPANIC MEDICAL ASSOCIATION
1920 L STREET NW SUITE 725WASHINGTONDC20036521884446501(C)(6)$30,000$0AWARD
NATIONAL PSORIASIS FOUNDATION
6600 SW 92ND AVE SUITE 300PORTLANDOR97223930571472501(C)(3)$15,000$0SUPPORT
NATIONAL URBAN LEAGUE INC
80 PINE STREET 9TH FLOORNEW YORKNY10005131840489501(C)(3)$150,000$0GIFT
NCSL FOUNDATION FOR STATE LEGISLATURES
7700 EAST FIRST PLACEDENVERCO80230742232576501(C)(3)$7,500$0SPONSORSHIP
NUS AMERICA FOUNDATION INC
440 NORTH WOLFE ROADSUNNYVALECA94085202368621501(C)(3)$16,000$0DONATION
OREGONIANS FOR FOOD AND SHELTER
1149 COURT ST NE SUITE 110SALEMOR97301930775640501(C)(6)$17,500$0SUPPORT
PREVENT BLINDNESS
225 WEST WACKER DRIVE SUITE 400CHICAGOIL60606363667121501(C)(3)$15,500$0SUPPORT
PREVENT CANCER FOUNDATION
1600 DUKE ST SUITE 500ALEXANDRIAVA22314521429544501(C)(3)$8,000$0SPONSORSHIP
RESEARCHAMERICA
241 18TH STREET SOUTH SUITE 501ARLINGTONVA22202521609875501(C)(3)$6,000$0SUPPORT
SERVICES AND ADVOCACY FOR GAY LESBIAN BISEXUAL AND TRANSGENDER ELDERS IN
305 7THAVE 15TH FLOORNEW YORKNY10001132947657501(C)(3)$20,000$0SUPPORT
SICK CELLS
4512 RIVER DRIVELISLEIL60532813481633501(C)(3)$65,000$0SUPPORT
ST BALDRICK'S FOUNDATION
1333 S MAYFLOWER AVE SUITE 400MONROVIACA91016201173824501(C)(3)$15,000$0SUPPORT
SYNGAP1 FOUNDATION
15319 REDBUD BERRY WAYCYPRESSTX77433472459997501(C)(3)$15,000$0SUPPORT
THE BRIGHAM AND WOMEN'S HOSPITAL INC
75 FRANCIS ST MAIL CODE 300 FENWAYBOSTONMA02115042312909501(C)(3)$10,000$0SPONSORSHIPR
THE CONGRESSIONAL INSTITUTE INC
1700 DIAGONAL RD SUITE 300ALEXANDRIAVA22314521504189501(C)(4)$15,000$0SUPPORT
THE GERONTOLOGICAL SOCIETY OF AMERICA
1220 L STREET NW 901WASHINGTONDC20005521256181501(C)(3)$10,000$0SUPPORT
THE GLOBAL FOUNDATION FOR PEROXISOMAL DISORDERS
PO BOX 33238TULSAOK74135273646193501(C)(3)$15,000$0SUPPORT
THE GLOBAL WOMEN'S INNOVATION NETWORK
233 PENNSYLVANIA AVENUE SE 2NDWASHINGTONDC20003271428117501(C)(3)$50,000$0SUPPORTFLOOR
THE GOVERNING MAJORITY EDUCATION FUND
606 W WISCONSIN AVE 1202MILWAUKEEWI53203850549304501(C)(4)$25,000$0CONTRIBUTION
THE NATIONAL HEMOPHILIA FOUNDATION
7 PENN PLAZA SUITE 1204NEW YORKNY10001135641857501(C)(3)$15,000$0SUPPORT
THE ULMAN CANCER FUND OF YOUNG ADULTS INC
2118 E MADISON STBALTIMOREMD21205522057636501(C)(3)$15,000$0SUPPORT
US CHAMBER OF COMMERCE
1615 H STREET NW P O BOX 1200WASHINGTONDC20062530045720501(C)(6)$25,000$0SUPPORT
UNITED SPINAL ASSOCIATION
120-34 QUEENS BLVD SUITE 320KEW GARDENSNY11415135612621501(C)(3)$10,000$0SUPPORT
US CHAMBER OF COMMERCE
1615 H STREET NW PO BOX 1200WASHINGTONDC20062530045720501(C)(6)$25,000$0SUPPORT
WOMEN OF COLOR IN PHARMA
PO BOX 6172SOMERSETNJ08875813871261501(C)(6)$10,000$0SPONSORSHIP
ZERO - THE PROJECT TO END PROSTATE CANCER
515 KING STREET SUITE 420ALEXANDRIAVA22314593400922501(C)(3)$15,000$0SUPPORT
FieldValueIRS element (for citing)
Total501c3 Org59Total501c3OrgCnt
Total Other Org80TotalOtherOrgCnt

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, LINE 2:FormAndLineReferenceDesc
ExplanationBIO RELIES ON THE REQUIRED QUALIFICATIONS OF THE GRANT RECIPIENTS TO PROVIDE ASSURANCE OF PROPER USAGE. IN SOME CASES, BIO PERSONNEL ATTEND EVENTS AND RECEIVE ACKNOWLEDGEMENTS RELATED TO THE FUNDS GRANTED.ExplanationTxt

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
First Class Or Charter TravelYes (X)FirstClassOrCharterTravelInd
Written Policy Ref T And E Expnss0WrittenPolicyRefTAndEExpnssInd
Substantiation RequiredYes (1)SubstantiationRequiredInd
Compensation CommitteeYes (X)CompensationCommitteeInd
Independent ConsultantYes (X)IndependentConsultantInd
Form990 Of Other OrganizationsYes (X)Form990OfOtherOrganizationsInd
Compensation SurveyYes (X)CompensationSurveyInd
Board Or Committee ApprovalYes (X)BoardOrCommitteeApprovalInd
Severance PaymentYes (1)SeverancePaymentInd
Supplemental Nonqual Rtr PlanYes (1)SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm0EquityBasedCompArrngmInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (8 entries)

TitleTitleTxtBase Compensation Filing OrgBaseCompensationFilingOrgAmtCompensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmtBonus Filing OrganizationBonusFilingOrganizationAmountBonus Related OrganizationsBonusRelatedOrganizationsAmtOther Compensation Filing OrgOtherCompensationFilingOrgAmtOther Compensation Rltd OrgsOtherCompensationRltdOrgsAmtDeferred Compensation Flng OrgDeferredCompensationFlngOrgAmtDeferred Comp Rltd OrgsDeferredCompRltdOrgsAmtNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmtNontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmtTotal Compensation Filing OrgTotalCompensationFilingOrgAmtTotal Compensation Rltd OrgsTotalCompensationRltdOrgsAmtComp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmtComp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
MICHELLE MCMURRY-HEATH
PRESIDENT AND CEO$1,197,646$0$851,887$0$600$0$233,700$0$30,922$0$2,314,755$0$0$0
THOMAS DILENGE
PRESIDENT, ADVOCACY/LAW/PUBLIC POLIC$210,960$0$522,501$0$622,515$0$8,700$0$30,396$0$1,395,072$0$0$0
RICH MASTERS
CHIEF PUBLIC AFFAIRS OFFICER$488,126$0$155,000$0$600$0$8,700$0$36,994$0$689,420$0$0$0
ELIZABETH ESHAM
CHIEF SCIENCE OFFICER$479,958$0$125,011$0$600$0$8,700$0$35,189$0$649,458$0$0$0
PETER MCHUGH
CHIEF LEGAL OFFICER$448,606$0$109,673$0$600$0$8,700$0$47,971$0$615,550$0$0$0
JOSEPH DAMOND
DEPUTY CHIEF POLICY OFFICER & EVP IN$409,070$0$123,988$0$600$0$26,200$0$51,691$0$611,549$0$0$0
SHAYE MANDLE
COO$471,585$0$50,000$0$600$0$0$0$33,551$0$555,736$0$0$0
STEPHEN JASKO
CHIEF FINANCIAL OFFICER$450,422$0$55,000$0$600$0$0$0$33,551$0$539,573$0$0$0

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, LINES 4A-BFormAndLineReferenceDesc
ExplanationTHE ORGANIZATION HAS A NONQUALIFIED DEFERRED COMPENSATION PLAN. UNDER THE TERMS OF THE PLAN, THE PARTICIPANTS ARE ENTITLED TO BENEFITS IF THEY REMAIN EMPLOYED BY THE ORGANIZATION UNTIL A PREDETERMINED TIME. THE PLAN IS INTENDED TO BE A NONQUALIFIED, UNFUNDED PROGRAM FOR THE BENEFIT OF A SELECT GROUP OF MANAGEMENT OR HIGHLY COMPENSATED EMPLOYEES OF BIO WITHIN THE MEANING OF ERISA. THE FOLLOWING WERE CONTRIBUTIONS MADE DURING 2021: MICHELLE MCMURRY-HEATH: $225,000 THOMAS DILENGE RECEIVED A ONE-TIME SEVERANCE PAYMENT OF $622,515 UPON SEPARATION OF SERVICE DURING THE TAX YEAR.ExplanationTxt

Schedule L IRS990ScheduleL

Bus Tr Involve Interested Prsn BusTrInvolveInterestedPrsnGrp

Name Of Interested NameOfInterested

FieldValueIRS element (for citing)
PersonLILY DOEFLERPersonNm
FieldValueIRS element (for citing)
Relationship DescriptionDAUGHTER OF A BOARD MEMBERRelationshipDescriptionTxt
Transaction$28,315TransactionAmt
TransactionEMPLOYMENTTransactionDesc
Sharing Of Revenues0SharingOfRevenuesInd

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (8 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
FORM 990, PART VI, SECTION A, LINE 1ATHE BOARD OF DIRECTORS SHALL DESIGNATE BY RESOLUTION AND WITH A QUORUM PRESENT, NOT MORE THAN TWENTY-THREE (23) DIRECTORS OF THE BOARD TO ACT AS AN EXECUTIVE COMMITTEE. THE EXECUTIVE COMMITTEE SHALL CONSIST OF THE SEVEN (7) ELECTED OFFICERS OF THE ORGANIZATION; THE IMMEDIATE PAST CHAIR OF THE ORGANIZATION; THE VICE CHAIRS OF EACH SECTION'S GOVERNING BOARD; AND THE BALANCE BEING AT-LARGE DIRECTORS FROM THE FULL BOARD. IF THE IMMEDIATE PAST CHAIR IS NO LONGER ELIGIBLE TO SERVE ON THE FULL BOARD, AN ADDITIONAL AT-LARGE DIRECTOR FROM THE FULL BOARD SHALL BE SELECTED FOR THE EXECUTIVE COMMITTEE. THE EXECUTIVE COMMITTEE SHALL HAVE, AND BE AUTHORIZED TO EXERCISE, ALL POWERS OF THE FULL BOARD, EXCEPT: (A) THE POWER TO ELECT OR REMOVE ELECTED OFFICERS OR DIRECTORS, TO CHANGE THE SIZE OF THE BOARD, TO CHANGE ELIGIBILITY, QUALIFICATIONS OR RIGHTS OF MEMBERSHIP, OR TO MAKE DETERMINATIONS AS TO DIRECTOR AND OFFICER COMPENSATION, WHERE APPLICABLE; AND (B) THE POWER TO AMEND THE ARTICLES OF INCORPORATION OR THE BYLAWS OF THE ORGANIZATION.
FORM 990, PART VI, SECTION A, LINE 6THE MEMBERS OF THE ORGANIZATION SHALL BE DIVIDED INTO FOUR CLASSES; CORE MEMBERS, ASSOCIATE MEMBERS, AFFILIATE MEMBERS, AND CENTER MEMBERS, DEFINED AS FOLLOWS: (A) CORE MEMBERS: ANY CORPORATION, PARTNERSHIP, ASSOCIATION, OR OTHER ENTITY ORGANIZED FOR PROFIT, A SUBSTANTIAL PERCENTAGE OF WHOSE BUSINESS ACTIVITIES INVOLVE BIOTECHNOLOGY, GENOMICS, BIOINFORMATICS OR RELATED NEW TECHNOLOGIES, IS ELIGIBLE FOR MEMBERSHIP. CORE MEMBERS ARE THOSE ENTITIES THAT UTILIZE BIOTECHNOLOGY, GENOMICS, BIOINFORMATICS OR OTHER RELATED NEW TECHNOLOGIES IN RESEARCH, DEVELOPMENT, TESTING, MANUFACTURING, OR SALES OF PRODUCT OR INFORMATION, AS WELL AS OTHER FIRMS THE BOARD SO CHARACTERIZES AND PLACES IN THIS CATEGORY. CORE MEMBERS SHALL BE GROUPED IN THE FOLLOWING SUBCATEGORIES: (I) EMERGING COMPANIES, WHICH ARE FIRMS THAT EMPLOY LESS THAN 350 PERSONS AND THAT DO NOT HAVE A THERAPEUTIC OR DIAGNOSTIC PRODUCT APPROVED FOR SALE IN THE U.S. MARKET; (II) ESTABLISHED FIRMS, WHICH ARE THOSE FIRMS THAT EMPLOY 350 OR MORE PERSONS OR THAT HAVE A THERAPEUTIC OR DIAGNOSTIC PRODUCT APPROVED FOR SALE IN THE U.S. MARKET; AND (III) LARGE FIRMS, WHICH ARE ESTABLISHED FIRMS THAT HAVE ANNUAL WORLDWIDE SALES OF BIOTECHNOLOGY PRODUCTS IN EXCESS OF $1.5 BILLION; AND (IV) NON-DOMESTIC COMPANIES, WHICH ARE CORE MEMBERS WITHOUT SIGNIFICANT OPERATIONS IN THE UNITED STATES OR SIGNIFICANT COLLABORATIONS WITH A U.S. ENTITY. (B) ASSOCIATE MEMBERS: ANY CORPORATION, PARTNERSHIP, ASSOCIATION, OR OTHER ENTITY ORGANIZED FOR PROFIT, A SUBSTANTIAL PORTION OF WHOSE ACTIVITIES INVOLVE PROVIDING SERVICES OR PRODUCTS OF BENEFIT TO COMPANIES WHOSE PRINCIPAL BUSINESS IS BIOTECHNOLOGY, IS ELIGIBLE FOR ASSOCIATE MEMBERSHIP. ASSOCIATE MEMBERS ARE THOSE COMMERCIAL ENTITIES WHICH DO NOT NECESSARILY UTILIZE BIOTECHNOLOGY; E.G. TECHNICAL SUPPORT, EQUIPMENT, CONSTRUCTION, ACCOUNTING, AND LAW FIRMS THAT SERVICE THE BIOTECHNOLOGY INDUSTRY, AS WELL AS OTHER FIRMS THAT THE BOARD CHARACTERIZES AND PLACES IN THIS CATEGORY. (C) AFFILIATE MEMBERS: ANY GOVERNMENTAL OR NONPROFIT ENTITY OR COUNTRY, STATE OR REGIONAL INDUSTRY, TRADE OR PROFESSIONAL ASSOCIATION WITH AN INTEREST IN, OR A MANDATE TO PROMOTE THE DEVELOPMENT OF, BIOTECHNOLOGY IS ELIGIBLE FOR AFFILIATE MEMBERSHIP. THERE SHALL BE NO SIZE TESTS APPLIED TO AFFILIATE MEMBER APPLICANTS. (D) CENTER MEMBERS: ANY INSTITUTION, NOT GENERALLY ELIGIBLE FOR CORE MEMBERSHIP THAT IS SPONSORED BY A STATE, REGION, OR ACADEMIC INSTITUTION AND WORKS IN SUPPORT OF COMMERCIAL BIOTECHNOLOGY MAY BE ELIGIBLE FOR CONSIDERATION AS A CENTER MEMBER.
FORM 990, PART VI, SECTION A, LINE 7AAT ALL MEMBERSHIP MEETINGS OF THE ORGANIZATION, EACH CURRENT MEMBER SHALL HAVE ONE (1) VOTE AND MAY TAKE PART IN THE VOTING IN PERSON OR BY PROXY. FOR EACH SECTION IN WHICH THE MEMBER PARTICIPATES, EACH MEMBER SHALL HAVE THE RIGHT TO VOTE ON THE ELECTION OF DIRECTORS FOR THE SECTION GOVERNING BOARD, BUT SHALL HAVE NO OTHER VOTING RIGHTS EXCEPT ON MATTERS BROUGHT TO THE MEMBERSHIP BY ANY SUCH GOVERNING BOARD OR THE ORGANIZATION'S BOARD OF DIRECTORS.
FORM 990, PART VI, SECTION B, LINE 11BTHE FORM 990 AND RELATED SCHEDULES ARE PREPARED BY THE ORGANIZATION'S CERTIFIED PUBLIC ACCOUNTANTS WITH INFORMATION PROVIDED BY AND UNDER THE GUIDANCE OF THE CHIEF FINANCIAL OFFICER (CFO). THE CFO AND THE CONTROLLER THOROUGHLY REVIEW ALL CALCULATIONS AND SCHEDULES TO CONFIRM THEY REFLECT THE ACTUAL FINANCIAL RESULTS OF THE ORGANIZATION. THE COMPLETE FORM 990 IS THEN REVIEWED INTERNALLY BY THE CFO, AND CONTROLLER IN CONSULTATION WITH LEGAL COUNSEL AND, AS APPROPRIATE, FURTHER CONSULTATION WITH THE ORGANIZATION'S CERTIFIED PUBLIC ACCOUNTANTS. ALL REVIEWS ARE COMPLETED BEFORE THE FORM IS FILED WITH THE IRS.
FORM 990, PART VI, SECTION B, LINE 12CBIOTECHNOLOGY INNOVATION ORGANIZATION (BIO) TAKES SEVERAL STEPS TO ADDRESS COMPLIANCE BY KEY EMPLOYEES, OFFICERS AND DIRECTORS WITH ITS CONFLICTS OF INTEREST POLICY. BIO TRAINS ALL NEW EMPLOYEES AND DIRECTORS ON VARIOUS ASPECTS OF BIO'S COMPLIANCE PROGRAM, INCLUDING CONFLICTS OF INTEREST, AND BIO'S WRITTEN CONFLICTS OF INTEREST POLICY REQUIRES ALL EMPLOYEES TO DISCLOSE ANY OUTSIDE PERSONAL BUSINESS INTERESTS TO THEIR SUPERVISOR. BIO'S GENERAL COUNSEL REGULARLY ADVISES BIO'S EXECUTIVES AND SUPERVISORS ON SUCH MATTERS. BIO ALSO CONTRACTS WITH AN INDEPENDENT ORGANIZATION TO PROVIDE EMPLOYEES AND OTHERS WITH THE ABILITY TO FILE ANONYMOUS REPORTS CONCERNING THE VIOLATION OF ANY LAWS OR BIO POLICIES, INCLUDING ALLEGATIONS OF POTENTIAL CONFLICTS OF INTEREST, AND BIO HAS A PROCESS IN PLACE TO FOLLOW UP ON ANY SUCH COMPLAINTS IN A TIMELY AND THOROUGH MANNER. FURTHER, BIO UNDERTAKES A QUESTIONNAIRE SENT TO EACH DIRECTOR ON ITS BOARD OF DIRECTORS SEEKING DISCLOSURE OF ANY POTENTIAL CONFLICTS OF INTERESTS THEY MAY HAVE, OR THEIR FAMILY MEMBERS MAY HAVE, ASSOCIATED WITH BUSINESSES OR ORGANIZATIONS THAT DO BUSINESS WITH BIO. POTENTIAL CONFLICTS ARE MONITORED AND REVIEWED AT THE MANAGEMENT AND SENIOR MANAGEMENT LEVEL OF THE ORGANIZATION, AND DEPENDING ON THE CONFLICT, DETERMINATIONS MAY BE MADE AT THE BOARD OR SENIOR MANAGEMENT LEVEL. A CONFLICT AT THE BOARD LEVEL WILL NORMALLY RESULT IN RECUSAL OF THE INDIVIDUAL FROM PARTICIPATION OR ACTIVITIES WITH RESPECT TO THE RELEVANT SUBJECT MATTER. AT THE STAFF LEVEL, THE APPLICABLE BIO SUPERVISOR IS INFORMED OF THE POTENTIAL CONFLICT AND IS REQUIRED TO TAKE ALL APPROPRIATE STEPS TO ENSURE THAT THE INDIVIDUAL DOES NOT PARTICIPATE IN, OR RECEIVE CONFIDENTIAL INFORMATION RELATING TO, ANY BIO ACTIVITY RELATED TO THE SUBJECT MATTER OF THE CONFLICT, UP TO AND INCLUDING, WHERE APPROPRIATE, TERMINATION OF SUCH EMPLOYEE.
FORM 990, PART VI, SECTION B, LINE 15FOR 2021, THE PRESIDENT AND CHIEF EXECUTIVE OFFICER (CEO) OF BIO (BIOTECHNOLOGY INNOVATION ORGANIZATION 52-1224577) WAS COMPENSATED PER THE TERMS OF A MULTI-YEAR CONTRACT THAT WAS DETERMINED WITH INDEPENDENT REVIEW, COMPARABILITY DATA, AND CONTEMPORANEOUS SUBSTANTIATION OF THE DELIBERATION AND DECISION, AS INDICATED IN PRIOR FORM 990 SUBMISSIONS. IN ADDITION, BASED ON THE EXECUTIVE COMMITTEE'S EVALUATION OF THE PRESIDENT AND CEO'S PERFORMANCE FOR 2021, THE COMMITTEE DETERMINED THE APPROPRIATE AMOUNT FOR THE DISCRETIONARY COMPONENT OF COMPENSATION FOR THAT YEAR, IN ACCORDANCE WITH THE RELEVANT PROVISION OF THE EXECUTIVE AGREEMENT. DECISIONS REGARDING THE COMPENSATION FOR OFFICERS AND KEY EMPLOYEES OF THE ORGANIZATION ARE NEGOTIATED INDIVIDUALLY AND ARE PERFORMANCE-BASED, IN ACCORDANCE WITH AN ANNUAL WRITTEN EVALUATION PROCESS THAT HAS BEEN ESTABLISHED FOR ALL EMPLOYEES OF THE ORGANIZATION. AN INDEPENDENT CONSULTANT PROVIDES COMPARATIVE BENCHMARKING SERVICES FOR SENIOR MANAGEMENT POSITIONS, AND OTHER INFORMATION ON COMPENSATION ISSUES, TRENDS, POLICIES, AND BEST PRACTICES FOR USE BY THE ORGANIZATION. THE ORGANIZATION ALSO HAS AN ESTABLISHED COMPENSATION POLICY FOR ALL OF ITS EMPLOYEES, WHICH SETS FORTH THE GENERAL PARAMETERS GOVERNING BIO'S COMPENSATION PRACTICES.
FORM 990, PART VI, SECTION C, LINE 19THE ORGANIZATION DOES NOT MAKE ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC.
FORM 990, PART IX, LINE 11GBIO-PAC ADMINISTRATIVE 29,094. BUSINESS STRATEGIES 4,034. CONSULTANTS AND OTHER PROFESSIONAL FEES 3,664,915. EC EMERGING PRIORITIES -38,110. ECONOMIC STUDIES 254,335. EDUCATION 222,222. I&E INITIATIVES 9,100. PROGRAM INITIATIVES 45,170. RECRUITMENT 233,749. RESEARCH/FOCUS GROUPS -7,500. TEMPORARY HELP 257,852. CBI LOBBYING FUND 1,062,280. SPECIAL INITIATIVES 7,274,523.

Schedule R IRS990ScheduleR

Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp (2 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdEINEINPrimary ActivitiesPrimaryActivitiesTxtLegal Domicile StateLegalDomicileStateCdExempt Code SectionExemptCodeSectionTxtControlled OrganizationControlledOrganizationIndPublic Charity StatusPublicCharityStatusTxt
EXCELLENCE THROUGH STEWARDSHIP
1201 MARYLAND AVE SW SUITE 900WASHINGTONDC20024263021330TO SUPPORT THE PURSUIT OF LIFELONG LEARNING ABOUT THE PROMISE, ACHIEVEMENTSDC501(C)(4)0
BIOTECHNOLOGY INSTITUTE
1201 MARYLAND AVE SW SUITE 900WASHINGTONDC20024251716917TO SUPPORT THE PURSUIT OF LIFELONG LEARNING ABOUT THE CHALLENGES OF BIOTECH.DC501(C)(3)0LINE 7
FieldValueIRS element (for citing)
Receipt Of Int Annts Rnts Rylts0ReceiptOfIntAnntsRntsRyltsInd
Gift Grnt Or Cap Contri To Oth OrgYes (1)GiftGrntOrCapContriToOthOrgInd
Gift Grnt Cap Contri From Oth Org0GiftGrntCapContriFromOthOrgInd
Loans Or Guarantees To Other OrgYes (1)LoansOrGuaranteesToOtherOrgInd
Loans Or Guarantees From Oth Org0LoansOrGuaranteesFromOthOrgInd
Div Related Organization0DivRelatedOrganizationInd
Asset Sale To Other Org0AssetSaleToOtherOrgInd
Asset Purchase From Other Org0AssetPurchaseFromOtherOrgInd
Asset Exchange0AssetExchangeInd
Rental Of Facilities To Oth Org0RentalOfFacilitiesToOthOrgInd
Rental Of Fclts From Oth Org0RentalOfFcltsFromOthOrgInd
Perform Of Services For Oth Org0PerformOfServicesForOthOrgInd
Perform Of Services By Other Org0PerformOfServicesByOtherOrgInd
Sharing Of Facilities0SharingOfFacilitiesInd
Paid Employees Sharing0PaidEmployeesSharingInd
Reimbursement Paid To Other Org0ReimbursementPaidToOtherOrgInd
Reimbursement Paid By Other OrgYes (1)ReimbursementPaidByOtherOrgInd
Transfer To Other Org0TransferToOtherOrgInd
Transfer From Other Org0TransferFromOtherOrgInd

Transactions Related Org TransactionsRelatedOrgGrp (4 entries)

Transaction TypeTransactionTypeTxtInvolvedInvolvedAmt
EXCELLENCE THROUGH STEWARDSHIP
B$54,996
EXCELLENCE THROUGH STEWARDSHIP
Q$38,371
THE BIOTECHNOLOGY INSTITUTE
D$84,004
THE BIOTECHNOLOGY INSTITUTE
B$55,240